Dec 9, 2025 08:07AM
Dec 9, 2025 08:05AM
Sep 16, 2025 08:34AM
Sep 16, 2025 08:30AM
Aug 8, 2025 09:00AM
Feb 15, 2025 06:59PM
Nov 20, 2024 08:35AM First Patient Dosed in Aptevo's Ongoing RAINIER Trial Achieves 90% Reduction in Leukemic Blasts Within the First 30 Days of Treatment, Continues Overall Efficacy Trend Seen in Prior Mipletamig AML Stu
Mar 5, 2024 08:05AM
Mar 30, 2023 07:47AM
Mar 30, 2023 07:45AM
Nov 10, 2022 08:05AM
Nov 9, 2022 08:08AM
Nov 9, 2022 08:05AM
Aug 11, 2022 08:05AM Aptevo Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights
May 27, 2021 09:03AM
May 27, 2021 09:00AM
Mar 31, 2021 08:00AM
Nov 19, 2020 09:26AM
Nov 18, 2020 05:42PM
Nov 10, 2020 04:40PM
Aug 14, 2020 09:00AM Aptevo Therapeutics Reports Second Quarter 2020 Financial Results
Jun 25, 2020 09:05AM
Jun 25, 2020 09:00AM
Feb 28, 2020 08:59AM
Feb 28, 2020 08:59AM
Jan 13, 2020 08:00AM
Dec 6, 2019 09:03AM
Dec 6, 2019 09:00AM Aptevo Therapeutics Receives Orphan Drug Designation for APVO436 for the Treatment of Acute Myelogenous Leukemia
May 9, 2019 09:00AM
Apr 15, 2019 09:00AM
Nov 15, 2018 09:23AM
Aug 9, 2018 09:00AM
May 29, 2018 09:06AM
May 29, 2018 09:00AM
May 10, 2018 09:00AM Aptevo Therapeutics Reports First Quarter 2018 Financial Results
May 1, 2018 09:05AM
May 1, 2018 09:00AM
Sep 28, 2017 06:05PM
Sep 1, 2017 09:23AM
Aug 31, 2017 06:06PM
Jan 4, 2017 07:58AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All